This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you are a person with diabetes, or would like more information on diabetes, please refer to our partner charity, the Diabetes Research & Wellness Foundation (DRWF).

Visit Charity?

News

IMAGE

03 Jun 2020

Abbott steps in to help thousands of people with diabetes amid COVID-19

Frontline workers looking after people with diabetes in hospital amid the COVID-19 pandemic will receive innovative devices to help them “monitor glucose levels” better at a safer distance.

Abbott, which produces the pioneering FreeStyle Libre system, has announced it is donating thousands of the world's leading sensor-based glucose monitoring technology to hospitals.

This will allow frontline healthcare workers to monitor peoples’ glucose status better while in the hospital and also remotely once they have been discharged.

Up to 6,500 FreeStyle Libre sensors are being handed over which will equip as many as 3,250 at-risk people who are living with diabetes for a month, so they can go home sooner and stay connected with their healthcare professional post-discharge, helping them to stay well.

Dr Pratik Choudhary, senior lecturer and consultant in diabetes, Kings College Hospital, London and co-chair of the Diabetes Technology Network (DTN ), said: “Recent data shows that people with diabetes have an elevated risk of adverse outcomes with COVID-19, which is also linked to their glucose control.

“We are really pleased that Abbott has agreed to our request to help us support patients with diabetes who are admitted to hospital by donating FreeStyle Libre sensors.

“During the COVID-19 pandemic, we have been constantly looking for ways to limit unnecessary exposure between ourselves and patients, especially people with diabetes. The use of the FreeStyle Libre system will facilitate frequent monitoring of glucose for those who need it to control their blood glucose. It also allows us to view patient data remotely, supporting timely discharge with safe and effective remote follow-up.”

Neil Harris, general manager of Abbott's diabetes care business in the UK and Ireland, added: “Providing frontline healthcare professionals and patients with technology and equipment is critical in the fight against COVID-19.

“We’re delighted to make FreeStyle Libre sensors available for hospitalised people living with diabetes, which will help frontline healthcare workers to monitor and manage the glucose levels of these patients better and, at the same time, help limit COVID-19 exposure, helping to keep people safe.”

View all News
Loading

Twitter

Sponsors

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Abbott

 

Gold & Wifi Sponsor

  • GlucoRX

 

Gold Sponsor

  • Roche

 

Gold Sponsor

  • Insulet

 

The InterACT Diabetes Village

  • AstraZeneca

 

Registration Sponsor

  • Diabetes Research & Wellness Foundation

 

Partners

Event Partner

  • NHS

Event Partner

  • ABCD

Event Partner

  • Diabetes Times

Event Partner

  • Trend

Media Partner

  • Caring Uk

Media Partner

  • Care Hub

Media Partner

  • Lifestyle Hub

Media Partner

  • Hospital Hub

Media Partner

  • Hub News

Media Partner

  • Practical Diabetes

Media Partner

  • Prescriber